Product Name: Insulin antibody [INSC7C9], C-term
Applications: ELISA
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 6.20 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Protein A purified
Full Name: insulin
Background: After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5 region and with the IGF2 gene at the 3 region. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2010]
Synonyms: ILPR Antibody , MODY10 Antibody , IDDM2 Antibody , INS Antibody , IRDN Antibody
Cellular Localization:
CAS NO: 28448-85-3
Product: Liraglutide
Host: Mouse
Clonality: Monoclonal
Isotype: IgG1
Immunogen: Purified human insulin.
Antigen Species: Human
Species Reactivity: Human, Pig, Bovine
Conjugation: Unconjugated
Storage Buffer: PBS pH 7.4, 0.09% sodium azide
Storage Instruction: Keep as concentrated solution.Store at 4° C .
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: Reacts with C-terminal pentapeptide of insulin beta-chain. Cross-reacts with humanproinsulin, bovine insulin (30% ) and porcine insulin.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27154297?dopt=Abstract
